enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Amgen - Wikipedia

   en.wikipedia.org/wiki/Amgen

   2021: In March, the company announced it would acquire Five Prime Therapeutics and its lead candidate, bemarituzumab, for $1.9 billion. [93] [94] [95] In the same month, Amgen acquired Rodeo Therapeutics for $720 million. [96] [97] The FDA approved Amgen's Lumakras in May for treatment of patients with KRAS-G12C-mutated non-small cell lung ...

3. Amgen (AMGN) to Add Stomach Cancer Drug With Five Prime ... - AOL

   www.aol.com/news/amgen-amgn-add-stomach-cancer...

   Amgen (AMGN) inks a $1.9-billion deal to acquire clinical-stage biotech, Five Prime Therapeutics, to boost its oncology pipeline.

4. Brook Byers - Wikipedia

   en.wikipedia.org/wiki/Brook_Byers

   He is often featured on the Forbes Midas list and is currently on the board of directors of ten companies; CardioDX, Crescendo Bioscience, Inc., Genomic Health Incorporated, Five Prime Therapeutics, OptiMedica, HX Diagnostics, Pacific Biosciences, Inc., Tethys, Veracyte, Inc., and XDx, Inc. [4] Previously, he served on the board of directors of ...

5. Amgen Inks $1.9B Deal To Buy Five Prime Therapeutics ... - AOL

   www.aol.com/news/amgen-inks-1-9b-deal-091043469.html

   Amgen has agreed to snap up clinical-stage biotech Five Prime Therapeutics for an equity value of $1.9 billion, to strengthen the company’s oncology candidates. Five Prime shares surged 78.7% to ...

6. Why Five Prime's Stock Is Trading Higher Today - AOL

   www.aol.com/news/why-five-primes-stock-trading...

   It has the following product in pipeline: Cabiralizumab, FPA150, Bemarituzumab and Immuno-Oncology.Five Prime Therapeutics shares were trading up 20.53% at $5.30 on Monday. The stock has a 52-week ...

7. Five Prime Therapeutics Gets a New CFO - AOL

   www.aol.com/news/2013-10-23-five-prime...

   Clinical-stage biotech Five Prime Therapeutics has a new bean counter. The San Francisco-based novel protein developer announced today that Marc Belsky has taken on the role of chief financial ...

8. Is Five Prime Stock a Buy Right Now? This Is What You ... - AOL

   www.aol.com/news/five-prime-stock-buy-now...

   Change is in the air. A new President-elect and the possibility of an end to the pandemic. Some things, however, will always stay the same.Like small cap biotech stocks skyrocketing following the ...

9. Dorothee Kern - Wikipedia

   en.wikipedia.org/wiki/Dorothee_Kern

   Dorothee Kern, (born 1966) is a professor of Biochemistry at Brandeis University [2] and former player for the East German national basketball team. [3]In 2016, she cofounded Relay Therapeutics, [4] a Massachusetts-based drug research company studying the motion of proteins using genomic data and computational biology. [5]